13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001841857
Total reported value
$157.4M
$157.4M
67 檔
18.0%
During the Q2 2025 filing period, CM Management, LLC (CIK: 0001841857) submitted its Form 13F report to the U.S. SEC, disclosing a tracked public equity portfolio valued at $157.4M across 67 reported positions.
During Q2 2025, CM Management, LLC's portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ALCO | Alico Inc | Stock-Other | 6.70% | -1.64% | — | |
| 2 | TGB | Taseko Mines LTD | Stock-Other | 6.60% | — | -6.12% | |
| 3 | RIGL | Rigel Pharmaceuticals Inc | Stock-Other | 4.26% | +0.90% | — | |
| 4 | RLGT | Radiant Logistics Inc | Stock-Other | 4.15% | -0.10% | -3.23% | |
| 5 | PLPC | Preformed Line Products Co | Stock-Other | 4.07% | — | — | |
| 6 | BGC | Bgc Group Inc-a | Stock-Financials | 3.26% | -0.62% | +16.67% | |
| 7 | NMRK | Newmark Group Inc-class A | Stock-Other | 3.04% | -0.46% | — | |
| 8 | INTT | Intest CORP | Stock-Other | 2.79% | -3.77% | EXIT | |
| 9 | WBD | Warner Bros Discovery Inc | Stock-Comm Services | 2.61% | — | +66.67% | |
| 10 | AM6 | Amicus Therapeutics Inc | Stock-Other | 2.35% | — | — | |
| 11 | TALO | Talos Energy Inc | Stock-Other | 2.32% | +0.62% | NEW | |
| 12 | SABR | Sabre CORP | Stock-Tech | 2.30% | -0.02% | +14.29% | |
| 13 | CLPT | Clearpoint Neuro Inc | Stock-Other | 2.17% | +0.28% | +14.29% | |
| 14 | RBCAA | Republic Bancorp Inc-class A | Stock-Other | 2.13% | -0.05% | -8.57% | |
| 15 | ARKO | Arko CORP | Stock-Other | 2.12% | +0.05% | -33.33% | |
| 16 | PK | Park Hotels & Resorts Inc | Stock-Real Estate | 2.10% | -0.39% | +12.50% | |
| 17 | VTRS | Viatris Inc | Stock-Healthcare | 2.03% | -0.21% | +11.11% | |
| 18 | OGN | Organon & Co | Stock-Healthcare | 1.98% | +0.36% | +50.00% | |
| 19 | HZO | Marinemax Inc | Stock-Other | 1.83% | +0.07% | — | |
| 20 | CGAU | Centerra Gold Inc | Stock-Other | 1.81% | — | -21.43% | |
| 21 | BB3 | Brookline Bancorp Inc | Stock-Other | 1.73% | — | — | |
| 22 | IQV | Iqvia Holdings Inc | Stock-Healthcare | 1.72% | — | — | |
| 23 | ARKR | Ark Restaurants CORP | Stock-Other | 1.64% | -0.39% | — | |
| 24 | AVIR | Atea Pharmaceuticals Inc | Stock-Other | 1.64% | -0.55% | — | |
| 25 | CHRS | Coherus Oncology Inc | Stock-Other | 1.50% | -1.10% | +4.77% | |
| 26 | XOMA | Xoma Royalty Corporation | Stock-Other | 1.47% | -1.05% | EXIT | |
| 27 | EOLS | Evolus Inc | Stock-Other | 1.47% | +0.39% | +16.67% | |
| 28 | CTSO | Cytosorbents CORP | Stock-Other | 1.46% | -0.35% | +31.02% | |
| 29 | PD | Pagerduty Inc | Stock-Other | 1.39% | +0.23% | -33.33% | |
| 30 | THFF | First Financial CORP | Stock-Other | 1.38% | -1.59% | EXIT | |
| 31 | HRTX | Heron Therapeutics Inc | Stock-Other | 1.13% | -0.40% | — | |
| 32 | IOVA | Iovance Biotherapeutics Inc | Stock-Other | 1.10% | -0.13% | +40.00% | |
| 33 | NKTR | Nektar Therapeutics | Stock-Other | 1.06% | — | — | |
| 34 | WGO | Winnebago Industries | Stock-Other | 1.06% | +1.20% | — | |
| 35 | COYA | Coya Therapeutics Inc | Stock-Other | 1.05% | +0.25% | — | |
| 36 | PFE | Pfizer Inc | Stock-Healthcare | 0.99% | +0.31% | NEW | |
| 37 | ELDN | Eledon Pharmaceuticals Inc | Stock-Other | 0.93% | -0.23% | +36.36% | |
| 38 | VTOL | Bristow Group Inc | Stock-Other | 0.90% | — | — | |
| 39 | DIT | Amcon Distributing Co | Stock-Other | 0.90% | -0.40% | +2.26% | |
| 40 | RNR | RenaissanceRe Holdings Ltd. | Stock-Financials | 0.88% | — | — | |
| 41 | SVC | Service Properties Trust | Stock-Other | 0.87% | -0.19% | -11.11% | |
| 42 | CGNT | Cognyte Software Ltd. | Stock-Other | 0.84% | -0.63% | — | |
| 43 | APA | Apa CORP | Stock-Energy | 0.83% | — | — | |
| 44 | CPA | Copa Holdings, S.A. | Stock-Other | 0.80% | +0.95% | — | |
| 45 | IOSP | Innospec Inc | Stock-Other | 0.77% | +0.18% | — | |
| 46 | FSLR | First Solar Inc | Stock-Tech | 0.75% | — | — | |
| 47 | ADBE | Adobe Inc | Stock-Tech | 0.70% | — | — | |
| 48 | OSTX | Os Therapies Inc | Stock-Other | 0.64% | +0.01% | +25.00% | |
| 49 | EG | Everest Group, Ltd. | Stock-Financials | 0.62% | +1.20% | — | |
| 50 | SLB | Slb LTD | Stock-Energy | 0.62% | — | — |
According to official SEC Form 13F filings, CM Management, LLC reported a total U.S. public equity portfolio value of $157.4M across 67 disclosed positions in Q2 2025.
During Q2 2025, CM Management, LLC's top holdings by market value included ALCO (6.7%)、TGB (6.6%)、RIGL (4.3%). The largest single position, ALCO, represented 6.7% of total portfolio value.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including ALCO, TGB, RIGL) accounted for 18.0% of total reported equity market value during Q2 2025.
In Q2 2025, CM Management, LLC made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.